← Back to Search

N/A

Treatment for Atrial Fibrillation (RAFT-AF Extend Trial)

N/A
Recruiting
Research Sponsored by Anthony Tang
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients previously enrolled and randomized in the RAFT-AF Study that are eligible to enroll
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Summary

This is an extended follow up study of the original RAFT-AF Study. The RAFT-AF study was a multi-centre randomized controlled trial with a prospective randomized open blinded endpoint trial (PROBE) design. Patients were randomized to either catheter ablation-based rhythm control of AF as compared to rate control of AF

Eligible Conditions
  • Atrial Fibrillation
  • Heart Failure

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite of mortality and Heart Failure Events
Secondary outcome measures
Heart Failure Events
all-cause mortality

Find a Location

Who is running the clinical trial?

Anthony TangLead Sponsor
2 Previous Clinical Trials
2,500 Total Patients Enrolled
~0 spots leftby Sep 2024